This is a non-core endpoint: only basic statistics are computed.
Explicit viral Sepsis
AB1_SEPSIS_VIRAL_EXPL
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
21 |
4. Check minimum number of eventsNone |
21 |
5. Include endpointsNone |
21 |
6. Filter based on genotype QC (FinnGen only) |
21 |
Control definitions (FinnGen only)
- Control exclude
- AB1_SEPSIS_EXPLICIT, AB1_SEPSIS_IMPLICIT
Extra metadata
- First used in FinnGen datafreeze
- DF8
Similar endpoints
↥List of similar endpoints to
Explicit viral Sepsis
based on the number of shared cases.
Similar with more cases:
- Herpesviral [herpes simplex] infections
- Viral Sepsis
- Viral infections characterized by skin and mucous membrane lesions
- Explicit Sepsis
- Certain infectious and parasitic diseases
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 21 | 10 | 11 |
| Unadjusted period prevalence (%) | 0.00 | 0.00 | 0.00 |
| Median age at first event (years) | 38.56 | 33.02 | 43.61 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3048929) Epstein Barr virus Ab [Presence] in Serum
7
8
12.33
4.13
1.3
1.3
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
7
11
8.88
3.51
1.1
1.5
g/l
68.9
68.4
—
7
11
(3018677) aPTT in Platelet poor plasma by Coagulation assay
8
20
5.77
2.93
2.3
3.0
s
35.6
31.1
—
8
20
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
5
6
10.40
2.91
1.4
1.0
g/l
10.0
12.5
—
5
6
(3005719) IgG [Mass/volume] in Serum or Plasma
6
11
7.12
2.75
3.0
2.1
g/l
11.4
10.6
—
6
11
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
5
7
8.89
2.70
1.2
1.0
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
5
7
8.89
2.70
1.8
1.0
u/ml
5392.8
291.0
—
5
7
(3007853) Bacteria identified in Skin by Aerobe culture
7
17
5.61
2.62
1.9
1.5
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
7
19
4.97
2.40
1.6
1.6
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
12
54
3.83
2.36
8.8
5.7
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
5
10
6.16
2.20
1.2
1.7
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
5
12
5.09
1.94
3.8
8.1
u/l
270.4
237.0
—
5
12
(3015736) pH of Urine
13
68
3.37
1.84
6.5
2.8
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
13
72
3.10
1.77
9.8
5.7
mmol/l
1.2
1.2
0.35
13
61
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
7
28
3.23
1.62
2.0
1.5
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
12
66
2.89
1.56
3.4
2.5
ug/l
240.3
90.6
0.39
12
60
(40758558) Short blood count panel - Blood
9
44
2.81
1.52
4.3
5.2
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
9
44
2.81
1.52
5.2
6.5
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
5
17
3.52
1.45
2.4
1.5
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
8
36
2.96
1.44
8.5
3.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
10
51
2.83
1.40
1.9
1.5
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
5
19
3.12
1.29
1.4
1.5
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
9
46
2.66
1.26
4.7
4.2
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
5
20
2.95
1.22
7.8
6.2
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
5
20
2.95
1.22
1.4
1.5
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
6
27
2.70
1.03
3.7
1.7
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
6
28
2.59
1.01
2.3
1.7
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
7
38
2.25
0.85
2.0
2.0
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
7
43
1.94
0.76
1.4
1.3
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
8
48
2.07
0.75
3.5
3.5
%
111.8
94.8
—
8
48
(3042936) Bacteria identified in Isolate by Culture
5
27
2.11
0.74
2.4
1.8
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
10
65
2.03
0.72
9.7
3.2
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
11
75
1.98
0.69
3.4
4.3
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
15
176
0.48
0.66
3.3
3.5
mmol/l
1.1
1.3
0.21
15
165
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
10
67
1.94
0.65
2.3
2.7
nmol/l
69.2
78.3
—
10
57
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
16
131
1.92
0.61
7.2
3.7
pmol/l
14.8
15.0
0.11
16
118
(3013826) Glucose [Moles/volume] in Serum or Plasma
13
100
1.78
0.59
9.5
3.4
mmol/l
6.4
6.2
0.15
13
91
(3026008) Bacteria identified in Urine by Culture
7
47
1.73
0.55
4.1
2.0
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
9
65
1.67
0.49
9.9
2.0
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
5
30
1.87
0.48
1.4
1.4
—
945.5
—
0
11
(3026782) Osmolality of Urine
5
32
1.73
0.46
6.2
2.0
mosm/kgh2o
558.8
591.1
—
5
27
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
5
33
1.67
0.45
2.2
2.1
mmol/l
2.4
2.4
—
5
27
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
5
33
1.67
0.45
2.2
1.5
pmol/l
275.2
487.8
—
5
28
(3020564) Creatinine [Moles/volume] in Serum or Plasma
21
195
+∞
0.43
26.8
13.2
umol/l
76.7
75.0
0.09
21
195
(3021960) Folate [Moles/volume] in Serum or Plasma
5
37
1.46
0.26
1.2
1.5
nmol/l
23.8
21.5
—
5
30
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
5
39
1.37
0.25
2.2
1.7
—
—
—
0
0
(3013512) EKG study
5
41
1.29
0.24
23.6
3.8
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
11
128
0.70
0.23
4.4
3.1
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
6
50
1.28
0.22
1.7
3.0
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
0
10
0.00
0.22
0.0
1.2
—
2.0
—
0
5
(3044889) 12 lead EKG panel
14
125
1.36
0.19
9.5
2.9
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
6
53
1.18
0.10
7.0
2.1
e6/l
0.4
0.2
—
6
35
(40768804) Tissue Pathology biopsy report
6
72
0.77
0.09
3.5
1.8
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
14
133
1.16
0.09
13.6
6.9
u/l
85.0
72.7
0.72
14
128
(3037467) Urinalysis macro (dipstick) panel - Urine
13
122
1.17
0.09
6.3
3.4
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
0
5
0.00
0.00
0.0
4.4
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
7
70
1.00
0.00
4.3
4.7
ug/l
2.3
2.0
—
7
61
(36304419) Bacteria [Presence] in Urine
5
51
0.97
0.00
7.6
1.9
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3022313) Gas panel - Capillary blood
0
7
0.00
0.00
0.0
4.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
0
8
0.00
0.00
0.0
2.6
—
216.9
—
0
8
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
0
7
0.00
0.00
0.0
1.3
—
96.7
—
0
7
(4306422)
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
5
48
1.05
0.00
8.2
2.9
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(4268621)
0
7
0.00
0.00
0.0
2.4
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
3.3
—
14.8
—
0
6
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: AB1_SEPSIS_VIRAL_EXPL – Explicit viral Sepsis
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).